Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. engages in the development and manufacture of biopharmaceutical focused on antibody drugs. It provides clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. Its products include yisaipu and jiannipai. The company was founded on January 25, 2002 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company